NEXT BIOMETRICS GROUP AS (NEXT.OL) Stock Income Statement
OSL:NEXT - Euronext Oslo - NO0010629108 - Common Stock - Currency: NOK
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 65.67M | 71.57M | 34.38M | 48.29M | 50.76M | |||
| Cost Of Goods | 29.07M | 32.42M | 27.00M | 33.54M | 41.78M | |||
| Gross Profit | 36.59M | 39.16M | 7.38M | 14.75M | 8.97M | |||
| Operating Expenses | 84.21M | 85.23M | 72.66M | 62.87M | 67.22M | |||
| Research and Development | 22.56M | 22.26M | 13.23M | 12.09M | 5.50M | |||
| Selling, General, and Administrative Expenses | 37.99M | 33.24M | 42.54M | 33.39M | 45.95M | |||
| Operating Income | -47.61M | -46.07M | -65.28M | -48.12M | -58.25M | |||
| Interest Income/Expense | N/A | 1.01M | 677.00K | 1.66M | 470.00K | |||
| Other Income/Expense | 181.00K | 21.00K | 241.00K | 13.00K | -614.00K | |||
| Non Recurring Items | 0.00 | 0.00 | -1.14M | 52.00K | 0.00 | |||
| Income Before Taxes | -47.43M | -45.04M | -65.50M | -46.39M | -58.39M | |||
| Income Tax | 139.00K | 197.00K | 234.00K | -60.00K | 1.62M | |||
| Net Income | -47.57M | -45.23M | -65.73M | -46.33M | -60.01M | |||
| EBITDA | -42.57M | -40.67M | -58.21M | -40.89M | -51.18M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.41 | -0.42 | -0.69 | -0.50 | -0.67 | |||
| Non GAAP EPS | N/A | N/A | N/A | -0.51 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 55.73% | 54.71% | 21.46% | 30.55% | 17.68% | |||
| Profit Margin | -72.44% | -63.20% | -191.18% | -95.94% | -118.24% | |||
| Operating Profit Margin | -72.51% | -64.36% | -189.85% | -99.65% | -114.77% | |||
All data in NOK